Conference Chair
Michael Graner Professor, University of Colorado Anschutz School of Medicine |
Keynote Speakers
Jan Lötvall Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles |
Dominique PV de Kleijn Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands |
Dana Larocca VP Discovery Research, AgeX Therapeutics |
Paul Robbins Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School |
Susanne Gabrielsson Professor, Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet |
My Mahoney Professor and Vice Chair, Thomas Jefferson University |
|
Behzad Mahdavi Vice President of Strategic Innovation & Alliances, Lonza |
Min Yu Assistant Professor, University of Southern California |
Chulhee Choi Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, ILIAS Biologics Incorporated |
Jennifer Jones NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute |
Mei He Assistant Professor, University of Kansas and Chief Science Officer of Clara Biotech |
John Nolan CEO, Cellarcus Biosciences, Inc. |
Raghu Kalluri Professor and Chairman, Department of Cancer Biology, University of Texas MD Anderson Cancer Center |
Dolores Di Vizio Professor, Cedars Sinai Medical Center |
Lorraine O’Driscoll Professor in Pharmacology, Trinity College Dublin |
Steven Stice Co-Founder and Chief Scientific Officer, Aruna Bio; DW Brook Distinguished Professor and Director of the Regenerative Bioscience Center, Georgia Research Alliance Eminent Scholar, University of Georgia |
Daniel Chiu A. Bruce Montgomery Professor of Chemistry, University of Washington |
Lucia Languino Professor of Cancer Biology, Thomas Jefferson University |
Randolph Corteling Head of Research, ReNeuron Ltd. |
OverviewSelectBIO EV-based Diagnostics, Delivery & Therapeutics 2020 Conference brings together the most up-to-date technologies and advances in this
expanding and evolving field. Our coverage in this conference focuses
on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas: - Extracellular Vesicles (EVs): Exosomes and Microvesicles -- Research Activities
- Exosome/EV Engineering -- Engineered Exosomes for Delivery
- Drug Delivery via Engineered Vesicles
- Exosomes/EV-based Therapeutics Development
This
conference features an international faculty of speakers from academia
as well as industry addressing the following topic areas: - Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
- Role in Cancer and Various Disease Classes
- Biomarker Potential for Diagnostics Development
- Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
The ability to engineer EVs and the ability of EVs to target specific
sites offers the ability to tailor therapeutics with "exquisite targeting
ability" and opens up a whole new class of therapeutics which are
classified as biologicals and which do not have the side effects and
toxicity associated with small molecule-based therapies. This conference explores this topic and takes a deep dive into the technology
platforms, diseases targeted and clinical results-to-date.
|
Slide Deck Downloads: Exosomes Technology Analysis Slide Deck 2018
Liquid Biopsy Slide Deck 2018
Registered
delegates receive access to the co-located concurrent conference
tracks, the co-located exhibit hall featuring companies from around the
world providing tools/technologies, products and services. Conference Presentations and Content Organization - Circulating Biomarkers 2020
- EV-based Diagnostics, Delivery and Therapeutics 2020
- EVs and Stem Cells Summit 2020 -- Speakers from this Track are in the Two Co-Located Tracks
|
Information and Local Registration Facilities for this Conference are Also Available In:
Japanese
|
Korean
|
Chinese (Simplified)
|
Chinese (Traditional)
Session Sponsors
Agenda Topics- Engineered Exosomes and Extracellular Vesicles (EVs) for Delivery
- Engineering EVs as Biologic Drugs
- Ex Vivo Production of Large Quantities of EVs: Challenges and Opportunities
- Exosomes-based Diagnostics/Liquid Biopsy Development
- Diagnostics Markers Carried by Exosomes
- Liquid Biopsy Enabled by Analyzing Exosomes
- Exosomes/EVs-based Drug Delivery
- Flow Cytometry and Single EV Analysis: A New Paradigm in Exosomes/EV Research
- Stem Cell-based EVs for Regenerative Medicine
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateJohnathon Anderson, Assistant Professor, University of California-Davis Mei He, Assistant Professor, University of Kansas and Chief Science Officer, Clara Biotech Sazid Hussain, Research Assistant Professor, Sanford Burnham Prebys Medical Discovery Institute Alina Lelic, Marketing Manager, North America, Beckman Coulter Juliane Nguyen, Associate Professor, University of North Carolina at Chapel Hill John Nolan, CEO, Cellarcus Biosciences, Inc. Robert Raffai, Professor, University of California-San Francisco Kendall Van Keuren-Jensen, Professor and Deputy Director, Translational Genomics Research Institute Aijun Wang, Chancellor's Fellow Professor, University of California-Davis Jim West, CEO, Clara Biotech William Whitford, Strategic Solutions Leader, GE Healthcare Life Sciences
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|